Cargando…
A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing
Background: Cutaneous squamous cell carcinoma (cSCC) incidence continues to rise with increasing morbidity and mortality, with limited treatment options for advanced disease. Future improvements in targeted therapy will rely on advances in genomic/transcriptomic understanding and the use of model sy...
Autores principales: | Hassan, Sakinah, Purdie, Karin J., Wang, Jun, Harwood, Catherine A., Proby, Charlotte M., Pourreyron, Celine, Mladkova, Nikol, Nagano, Ai, Dhayade, Sandeep, Athineos, Dimitris, Caley, Matthew, Mannella, Viviana, Blyth, Karen, Inman, Gareth J., Leigh, Irene M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678499/ https://www.ncbi.nlm.nih.gov/pubmed/31336867 http://dx.doi.org/10.3390/ijms20143428 |
Ejemplares similares
-
Key differences identified between actinic keratosis and cutaneous squamous cell carcinoma by transcriptome profiling
por: Lambert, S R, et al.
Publicado: (2014) -
The Genomic Landscape of Actinic Keratosis
por: Thomson, Jason, et al.
Publicado: (2021) -
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma
por: Cammareri, Patrizia, et al.
Publicado: (2016) -
Impact of Formate Supplementation on Body Weight and Plasma Amino Acids
por: Dhayade, Sandeep, et al.
Publicado: (2020) -
The Role of Human Papillomaviruses and Polyomaviruses in BRAF-Inhibitor Induced Cutaneous Squamous Cell Carcinoma and Benign Squamoproliferative Lesions
por: Purdie, Karin J., et al.
Publicado: (2018)